Literature DB >> 9931270

Ultrastructure of familial amyloid polyneuropathy amyloid fibrils: examination with high-resolution electron microscopy.

S Inoue1, M Kuroiwa, M J Saraiva, A Guimarães, R Kisilevsky.   

Abstract

The ultrastructure of familial amyloid polyneuropathy (FAP) amyloid fibrils was examined with high-resolution electron microscopy and immunolabeling. Sural nerve biopsies from FAP (Met 30) patients as well as control tissues were prepared for thin-section observations. Extracellular spaces in the vicinity of myelinated and unmyelinated peripheral nerves were found to be filled with amyloid fibrils as well as with deposits of an "amorphous" material. The fibril was composed of a surface layer and a core. The surface layer was made up of heparan sulfate proteoglycan and was externally associated with a loose assembly of 0.5- to 1-nm-wide filaments. The core was a microfibril-like structure in which amyloid P component was enclosed in a tight helical structure by chondroitin sulfate proteoglycan. Immunogold labeling showed that the peripheral fine filaments were composed of transthyretin. The dimensions of the transthyretin filament suggest that its basic unit is a modified monomer. The deposited amorphous material was a mixture of individual components of the fibril. These results suggest that the main body of FAP amyloid fibrils is similar to that of recently observed fibrils of experimental murine AA and hemodialysis-associated amyloid as well as of connective tissue microfibrils. The differences in the fibrils of these various types of amyloid are in the peripheral filaments which are composed of a protein specific to each type of amyloid. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9931270     DOI: 10.1006/jsbi.1998.4052

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  9 in total

1.  Ultrastructural organization of amyloid fibrils by atomic force microscopy.

Authors:  A K Chamberlain; C E MacPhee; J Zurdo; L A Morozova-Roche; H A Hill; C M Dobson; J J Davis
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.

Authors:  Steve Bourgault; James P Solomon; Natàlia Reixach; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

Review 3.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

4.  Synchrotron x-ray microdiffraction reveals intrinsic structural features of amyloid deposits in situ.

Authors:  Fatma Briki; Jérôme Vérine; Jean Doucet; Philippe Bénas; Barbara Fayard; Marc Delpech; Gilles Grateau; Madeleine Riès-Kautt
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

5.  Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition.

Authors:  Leonardo de C Palmieri; Luis Mauricio T R Lima; Juliana B B Freire; Lucas Bleicher; Igor Polikarpov; Fabio C L Almeida; Debora Foguel
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

6.  Early pathogenesis of cardiac amyloid deposition in senile systemic amyloidosis: close relationship between amyloid deposits and the basement membranes of myocardial cells.

Authors:  Motoji Sawabe; Akihiko Hamamatsu; Tateki Ito; Tomio Arai; Kumiko Ishikawa; Kouji Chida; Naotaka Izumiyama; Naoko Honma; Kaiyo Takubo; Masamitsu Nakazato
Journal:  Virchows Arch       Date:  2003-02-26       Impact factor: 4.064

7.  Uptake of aggregating transthyretin by fat body in a Drosophila model for TTR-associated amyloidosis.

Authors:  Malgorzata Pokrzywa; Ingrid Dacklin; Monika Vestling; Dan Hultmark; Erik Lundgren; Rafael Cantera
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

8.  Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.

Authors:  Jonathan S Wall; Emily B Martin; Tina Richey; Alan C Stuckey; Sallie Macy; Craig Wooliver; Angela Williams; James S Foster; Penney McWilliams-Koeppen; Ed Uberbacher; Xiaolin Cheng; Stephen J Kennel
Journal:  Molecules       Date:  2015-04-27       Impact factor: 4.411

9.  Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia.

Authors:  Jennifer L Ziskin; Michael D Greicius; Wan Zhu; Anna N Okumu; Christopher M Adams; Edward D Plowey
Journal:  Acta Neuropathol Commun       Date:  2015-07-10       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.